Related Experiment Video
Updated: Jun 1, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Relationship between plasma glucose levels and malignant uterine cervical neoplasias
Rosekeila Simões Nomelini1, Adriano Souza Lima Neto, Kalebe Alexandre Capuci
1Oncological Research Institute (IPON)/Discipline of Gynecology and Obstetrics.
Background:
There is a direct correlation between glycemic load and the risk of developing many malignant neoplasms.
Aims:
The aim of this study was to determine the plasma glucose levels in women with cervical cancer.
Methods:
The study included 177 women with anatomopathologically diagnosed uterine cervical cancer (stages 0-IV) treated between 1980 and 2008 at the Gynecology and Obstetrics outpatient service of the UFTM, Brazil. The plasma glucose levels of all patients were assayed at the time of diagnosis and correlated with tumor staging.
Results:
We statistically compared the plasma glucose levels of group 1 (cervical intraepithelial neoplasia 2-3), group 2 (stage I-II), group 3 (stage III-IV), and group 4 (control group: leiomyomas). Patient groups with poor prognosis (groups 2 and 3) showed significantly higher plasma glucose levels (P < 0.05) than those with less aggressive lesions (group 1). Plasma glucose levels were significantly higher in groups 2 and 3 than in group 4 (P < 0.05). The comparison of number of patients with plasma glucose level >90 mg/dl showed CIN versus I/II: P = 0.0753; OR = 2.018; (95% CI: 0.9236 to 4.410) and CIN versus III/IV: P = 0.0975; OR = 2.400; (95% CI: 0.8335 to 6.911).
Conclusion:
We observed an association between high plasma glucose levels and cervical cancer cases with poor prognoses. Plasma glucose tests should be routinely used as additional prognostic parameters in patients with cervical neoplasias.
Related Concept Videos
Hyperglycemia
Hypoglycemia and Glucagon
Hypoglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Cellular Adaptation IV: Dysplasia and Metaplasia